Sheep Pox Research Articles

Lumpy Skin Disease—An Emerging Cattle Disease in Europe and Asia

Lumpy skin disease virus (LSDV) is a member of the Capripoxvirus genus, mainly infecting cattle and buffalo, which until relatively recently was only endemic in parts of Africa and then spread to the Middle East and lately Europe and Asia. Lumpy skin disease (LSD) is a notifiable disease with a serious impact on the beef industry as it causes mortality of up to 10% and has impacts on milk and meat production, as well as fertility. The close serological relationship between LSDV, goat poxvirus (GTPV) and sheep poxvirus (SPPV) has led to live attenuated GTPV and SPPV vaccines being used to protect against LSD in some countries. There is evidence that the SPPV vaccine does not protect from LSD as well as the GTPV and LSDV vaccines. One of the LSD vaccines used in Eastern Europe was found to be a combination of different Capripoxviruses, and a series of recombination events in the manufacturing process resulted in cattle being vaccinated with a range of recombinant LSDVs resulting in virulent LSDV which spread throughout Asia. It is likely that LSD will become endemic throughout Asia as it will be very challenging to control the spread of the virus without widespread vaccination.

On-station comparative analysis of reproductive and survival performance between Red Maasai, Dorper, and Merino sheep breeds.

The reproductive performance of ewes and the survivability of lambs to weaning have a critical economic impact on sheep farming worldwide. Further, knowledge of major mortality causes allows an opportunity for improved flock management to evade financial losses. The maximum likelihood estimates for generalised linear mixed models and chi-square test methods were used to examine 971 mating records, 839 and 763 lambs born and weaned (singles or twins) from the Naivasha Sheep and Goats station in Kenya for the years 2011 to 2020 consisting of Dorper, Red Maasai (RedM), and Merino breeds. The RedM (P<0.05) outperformed Dorper and Merino in weaning rate, whereas reproductive performance between the three breeds was not significantly different (P>0.05) in litter size and multiple lambings per ewe lambing. On the one hand, Dorper significantly (P<0.05) outperformed the other two breeds only in weaning weight per lamb born. In addition, among all the major causes of death, pneumonia appeared to be the one to which Dorper breeds were most susceptible (chi-square test, P<0.05). According to the findings of this study, neither the Dorper nor the Merino sheep breeds were reproductively superior to the RedM in an extensive semi-arid production environment. In addition, Dorper's susceptibility to the leading causes of mortality, particularly pneumonia and sheep pox, were relatively high compared to other breeds and could be a precursor to massive economic losses for Dorper sheep producers. In contrast to the indigenous RedM breed, imported sheep breeds appeared to be more susceptible to major mortality-related under an extensive production system. Therefore, regardless of weaning weight, RedM breed production appears to be a more viable investment for small-scale farmers, particularly in semi-arid regions.

K-26 Sheep pox virus outbreak: Spanish experience

K-26 Sheep pox virus outbreak: Spanish experience

Molecular characterization of Capripoxvirus isolates from Moroccan sheep

Abstract Sheep pox is a highly contagious infectious viral disease (F/Poxviridae, G/Capripoxvirus), still causing economic damage in endemic zones like northern Africa, the Middle East, and many regions in Asia. Nevertheless, the clinical symptoms caused by sheep pox virus (SPPV) is similar to those caused by genetically related viruses, notably goat pox virus (GTPV) and lumpy skin disease virus (LSDV). One of the main objectives of the current study is to characterize the virus; nasal swabs were taken from sheep showing SPPV clinical signs, submitted to molecular sequencing based on the P32 gene marker, and proceeded to genetic comparisons. Phylogenetic results showed that all virus isolate sequences cluster in the SPPV clade, thus distinguishing them from those of GTPV and LSDV. These results give an accurate diagnostic and a clear view of endemic viral strains, guiding veterinary managers in control politics, especially in the choice of a homologous vaccine.

Comparative immunological changes in cattle vaccinated with sheep pox virus (RM-65) or sheep and goat pox virus (KSGP-0240) vaccines

Comparative immunological changes in cattle vaccinated with sheep pox virus (RM-65) or sheep and goat pox virus (KSGP-0240) vaccines

Spatiotemporal and seasonality analysis of sheep and goat pox (SGP) disease outbreaks in Turkey between 2010 and 2019.

Sheep and goat pox (SGP) is a highly infectious disease with a high case fatality rate. It causes serious economic losses and decreases productivity in infected facilities and contact areas. As in many countries of the world, SGP outbreaks reported from Turkey to the World Organization for Animal Health (OIE) continue to threaten animal health. Therefore, studies that will guide the production of effective policies to prevent and control SGP are extremely important. This study aims at evaluating the spatiotemporal distribution of SGP outbreaks by geographical information system (GIS)-based analyses. In accordance with this purpose, spatiotemporal scan analyses were applied to reveal the spatiotemporal distribution pattern and transmission of SGP outbreaks reported in Turkey between 2010 and 2019. Space-time cluster analysis revealed 4 several clusters, indicating geographic areas at the highest risk. Spatiotemporal clusters were 6 to 11 times more likely to be exposed to SGP than the general distribution. The average spatiotemporal density of outbreaks in clusters was estimated as 0.20 ± 0.07 outbreaks per 1000 km2 per month. Seasonal analysis and time series analysis showed similar findings. The seasonality of SGP was mainly defined in the winter (from December to February) when the seasonal adjusted factor (SAF) was at a peak of 504.6. In addition, February had the highest SAF with 7.1. Directional distribution analysis showed that the transmission of SGP was oriented between northeast (NE)-southwest (SW) and northwest (NW)-southeast (SE) and that distribution was changed every 2years. These findings present a basis for the effective monitoring and prevention of SGP and provide valuable information to policymakers.

The Serological Response in Cattle following Administration of a Heterologous Sheep Pox Virus Strain Vaccine for Protection from Lumpy Skin Disease; Current Situation in Armenia

Lumpy skin disease (LSD) is a highly infectious viral disease of cattle caused by LSD virus (LSDV), which was first reported in Armenia in late 2015. It was identified in pasture-raised cattle near the border with Iran. Currently, vaccination plays a key role in preventing further incursion of disease in high-risk areas. The purpose of this work was to assess the quality of vaccination currently used in Armenia by determining the immune response of the heterologous dry culture sheep pox virus-based vaccine against LSD in cattle. Seroprevalence and seroconversion testing was carried out using an ELISA to detect specific antibodies against LSD before and 30 days after vaccination in three adjacent regions of Armenia (Ararat, Armavir, Gegharkunik). Ixodes ticks were also examined for the presence of LSDV via real-time PCR. We found that the heterologous vaccine used in Armenia creates a high level of population immunity of 86.09% (83.83-87.97%) and no adverse side effects were observed in cattle. Of the 6 types of Ixodes ticks identified and tested, we found no evidence of LSDV circulating in these vectors. These results suggest that regular serological monitoring via ELISA and heterologous vaccination should continue in areas of Armenia at high risk for incursion of LSD to reduce the spread of this highly infectious transboundary disease.

A review on current epidemiology and molecular studies of lumpy skin disease virus-an emerging worldwide threat to domestic animals

In South Asia, cattle are afflicted by the expanding virulent condition known as Lumpy Skin Disease (LSD), and sheep pox and goat pox are caused by the Capri virus. These illnesses endanger worldwide trade. Due to inadequate immunisations and poverty in rural areas, Capricorn poxviruses are spreading. This is due to the economic repercussions of the COVID-19 epidemic, debilitating sanctions in endemic countries, a growth in the legal and criminal trade of live animals and animal products, and global climate change. Skin spores are the main route of infection; however, the virus is also excreted through bodily fluids and semen. As a result, the virus is transmitted to susceptible hosts by biting flies, mosquitoes, and other insects. Insects can be transstadial and transovarial. Lumpy skin disease lesions can swell and rupture after 7 to 14 days in experimental settings, but it usually takes 2 to 5 weeks in a normal infection. Lumpy skin disease is characterised by hard, constrictive, few (mild forms) to numerous (severe forms) skin nodules that may encompass respiratory, urogenital, and other organ mucous membranes. Consequently, milk output decreases, and in countries that raise cattle, there are more abortions, cases of temporary or permanent infertility, hide damage, and mortality, all of which result in a financial loss. The best method for limiting the spread and monetary impacts of lumpy skin disease is mass immunisation and other management measures. This review provides the latest information on lumpy skin disease's viral biology, transmission, clinical, and pathological aspects.

A recombinant capripoxvirus expressing the F protein of peste des petits ruminants virus and the P12A3C of foot-and-mouth disease virus

BackgroundPeste des petits ruminants (PPR), foot-and-mouth disease (FMD) and sheep pox and goat pox are three important infectious diseases that infect goats, sheep and other small ruminants. It is well-known that the prevention of three diseases rely mainly on their individual vaccines. However, the vaccines have a variety of different disadvantages, such as short duration of immunity, increasing the number of vaccinations, and poor thermal stability. The purpose of this study is to construct a recombinant goat pox virus (rGPV) capable of expressing the F gene of PPRV and the P12A3C gene of FMDV as a live vector vaccine.ResultsThe IRES, FMDV P12A3C and PPRV F genes into the multi-cloning site of the universal transfer plasmid pTKfpgigp to construct a recombinant transfer plasmid pTKfpgigpFiP12A3C, and transfected GPV-infected lamb testis (LT) cells with liposomes and produced by homologous recombination Recombinant GPV (rGPV/PPRVF-FMDVP12A3C, rGPV). The rGPV was screened and purified by green florescence protein (GFP) and xanthine-guanine-phosphoribosyltransferase gene (gpt) of Escherichia coli as selective markers, and the expression of rGPV in LT cells was detected by RT-PCR and immunofluorescence techniques. The results showed that the virus strain rGPV/PPRVF-FMDVP12A3C containing FMDV P12A3C and PPRV F genes was obtained. The exogenous genes FMDV P12A3C and PPRV F contained in rGPV were normally transcribed and translated in LT cells, and the expression products could specifically react with PPRV and FMDV antiserum. Then, the rGPV was intradermally inoculated with goats, the animal experiments showed that rGPV/PPRVF-FMDVP12A3C could induce high levels of specific antibodies against GPV, PPRV and FMDV.ConclusionsThe constructed rGPV induced high levels of specific antibodies against GPV, PPRV and FMDV. The study provides a reference for “ one vaccine with multiple uses “ of GPV live vector vaccine.

Isolation, adaptation, and characterization of lumpy skin disease virus from cattle in Bangladesh

Objective: The research aimed to isolate, adapt to cell culture, and characterize the lumpy skin disease virus (LSDV) from clinically infected cattle in Bangladesh. Materials and Methods: From September 2019 to June 2020, 37 skin nodules and skin swabs were aseptically collected from afflicted cattle in the outbreak regions of Jhenaidah and Kishoreganj in Bangladesh. The LSDV was isolated from embryonated specific pathogen-free (SPF) chicken eggs along the chorioallantoic membrane (CAM) route and the Vero cell line after several blind pas¬sages. The viral attachment protein was targeted for molecular detection using polymerase chain reactions (PCR). For phylogenetic analysis, PCR-positive products were partially sequenced. Results: The virus was evident in the cell line, showed cytopathic effects after the 13 blind pas¬sage, and on the CAM of SPF chicken eggs, exhibited thickening of the CAM with pock-like lesions. A total of 12 samples (32.43%) tested positive for LSDV by PCR. Phylogenetic analysis of the present isolates (accession numbers MN792649 and MN792650) revealed 100% similarity with strains from India (MN295064), Kenya (AF325528, MN072619, KX683219), Greece (KY829023), Serbia (KY702007), and Kazakhstan (MN642592); moreover, 99.43% to 100% similarity to the sheep pox virus. Conclusion: Partially sequenced LSDV was developed as a vaccine seed and was first isolated in Bangladesh and characterized at the molecular level.

Immunohistochemical Assessment of MDA and 8-OHdG Expression in the Skin, Lungs and Kidneys of Lambs Naturally Infected with Sheeppox Virus Confirmed with PCR

Immunohistochemical Assessment of MDA and 8-OHdG Expression in the Skin, Lungs and Kidneys of Lambs Naturally Infected with Sheeppox Virus Confirmed with PCR

Emergency vaccination of cattle against lumpy skin disease: Evaluation of safety, efficacy, and potency of MEVAC® LSD vaccine containing Neethling strain

Lumpy skin disease (LSD) is an emerging disease of cattle causing significantly high economic losses. Control of LSD depends on the use of homologous attenuated LSD virus strains isolated originally from South Africa (the Neethling strain). The virus belongs to the genus Capripoxvirus, which includes sheep pox virus and goat pox virus. The present study was conducted to evaluate the safety and efficacy of a new live attenuated LSD vaccine produced by Middle East for Vaccines (MEVAC®) based on the Neethling strain. Tests were performed both in Egypt and Vietnam. Safety was evaluated by inoculation of five cattle with 10 times the recommended dose and observation of the animals for 14 days. Immunogenicity was tested at different periods post-vaccination (PV) in animals receiving the recommended doses of the vaccine using ELISA and virus neutralization test. Five cows were used to determine the protection index (PI) and non-vaccinated control cattle were included. Three calves were challenged by intradermal inoculation of the wild virus (5 × 105 TCID50) 28 days PV. Field or mass vaccination experiments were conducted in Vietnam during national campaigns in the summer of 2021 with 4301 vaccinated animals closely monitored after vaccination. In the field, around 2% (80/4301) of the animals showed hyper-reactivity, and 0.6% (24/4301) showed small skin swellings that disappeared within few hours PV. Abortion was recorded in three animals (0.3% 3/867). Challenged animals were resistant to clinical disease and PI value was 3.5 log10. Meanwhile, antibody levels determined by the ELISA were inconsistent among animals and laboratories during the study period. Overall, the findings point to a new safe and effective LSD vaccine.

Seroprevalence and associated risk factors of pox infection among sheep and goats in selected districts of Afar region, Ethiopia

BackgroundSheep and goat pox virus infection is highly devastating viral disease of small ruminants that cause severe production losses in sheep and goats in Ethiopia and also limits international trade. A cross-sectional study was employed with the objective to estimate the seroprevalence of pox infection and to assess associated risk factors during the study period, February to April, 2020. A total of 384 serum samples were collected from apparently healthy sheep and goats. Serum neutralization test was used to detect the presence of antibodies against pox virus at national veterinary institute. Descriptive statistics, univariable and Multivariable logistic analyses were used in this study. ResultsThe overall animal level seroprevalence of sheep and goat pox virus was found to be 15.36% (n = 59/384) and species level prevalence rate was found to be 14.5% (n = 16/110) in sheep and 15.69% (n = 43/274) in goats in the study areas. Among the associated factors considered in this study, sex (P = 0.010), age (P = 0.012) and herd size (P = 0.029) were found to be statistically associated with seropositivity of pox infection in multivariable logistic regression. The odds of seropositivity in female animals were 3.9 times more likely to develop pox infection than male animals (AOR = 2.2; 95% CI = 1.203–4.015%) and the odds of young animals were 2.14 times more likely to be seropositive to pox infection than old aged animals (AOR = 2.14; 95% CI = 1.169–3.633%). Moreover, the odds of large-sized flocks of animals were 3.10 times more likely to be seropositive to pox disease than small-sized flocks (AOR = 3.10; 95% CI = 1.30–4.42%). ConclusionThis study finding revealed that sheep and goat pox virus is prevalent and widespread diseases of small ruminant in afar region. Therefore, further study should be carried out to estimate region wise magnitude of the disease and control measures should be put in place to minimize the economic losses associated with this disease.

Temporal dysregulation of genes in lamb testis cell during sheeppox virus infection.

The present study was aimed to elucidate the host-virus interactions using RNA-Seq analysis at 1 h and 8 h of post-infection of sheeppox virus (SPPV) in lamb testis cell. The differentially expressed genes (DEGs) and the underlying mechanisms linked to the host immune responses were obtained. The protein-protein interaction (PPI) network analysis and ingenuity pathway analysis (IPA) illustrated the interaction between the DEGs and their involvement in cell signalling responses. Highly connected hubs viz. AURKA, CHEK1, CCNB2, CDC6 and MAPK14 were identified through PPI network analysis. IPA analysis showed that IL-6- and ERK5-mediated signalling pathways were highly enriched at both time points. The TP53 gene was identified to be the leading upstream regulator that directly responded to SPPV infection, resulting in downregulation at both time points. The study provides an overview of how the lamb testis genes and their underlying mechanisms link to growth and immune response during SPPV infection.

Adaptation of the sheep pox virus (Poxviridae: &lt;i&gt;Capripoxvirus: Sheeppox virus&lt;/i&gt;) to African green monkey kidney cell line and evaluation of its immunobiological properties

Outbreaks of infectious diseases seriously hinder the preservation and increase of the number of small ruminants. Such infections include sheep pox virus (SPPV). According to the OIE data of 2021, SPP outbreaks were registered in countries such as Turkey, Israel, China, Maldives, Mongolia, Thailand, Russia, Algeria, Kenya, and in 2019 in Mangistau and Atyrau regions. In Kazakhstan annually conducts routine immunization of sheep at risk with a live attenuated vaccine produced by RIBSP. The object of the study was the vaccine strain of NISHI and the virulent strain A of the sheep pox virus. The virus was propagated in Vero cells. To determine the harmlessness and immunogenicity, sheep of the Kazakh fine-wool breed aged from 6 to 12 months were used. Virological, serological and immunobiological methods were used in the study. The results of the adaptation of the NISHI strain of SPPV to the Vero cell line are presented. Five passages in Vero cells resulted to the adaptation of the NISHI strain with the manifestation of a cytopathogenic effect specific to SPPV with a titer of 6.50 lg TCD50/ml. Following immunization, the formation of immunity was observed in animals on day 7 with an average protective titer 1.8 log2, which increased by day 21 to 4.33 log2. It has been established that the NISHI strain of SPPV retains its virological and immunobiological properties during reproduction in a Vero cell line.

Determination of the optimal immunizing dose of heterologous goat pox virus vaccine (Poxviridae: Chordopoxvirinae: Capripoxvirus) against lumpy skin disease

Lumpy skin disease (LSD), sheep pox and goat pox are dangerous diseases of domestic ruminants. Representatives of the genus of capripoxviruses are antigenically similar and can be used as a vaccine for three infections, as in the case of representatives of the genus of orthopoxviruses, which includes viruses of smallpox, monkeypox, and cowpox, that all belong to a single family Poxviridae. In this study, the vaccine strain G20-LKV of the goat pox virus and the virulent strain RIBSP2019/K of the LSD virus were used. The experiments were carried out on clinically healthy cattle of the Kazakh White-headed breed, aged six to eight months. Virological and serological research methods were used in the work. All immunized animals that received different doses of the vaccine showed resistance to the infection challenge, without showing any clinical signs of the disease. In animals that received the lowest doses of the vaccine 15,000, 30,000 and 40,000 TCID50, no adverse events, skin and temperature reactions were observed at the injection site. Those vaccinated with high doses of the vaccine had a local reaction in the form of swelling at the site of vaccine administration. Control animals infected with a virulent virus showed clinical signs of the cattle lumpy skin disease . The vaccine, prepared based on the "G20-LKV" strain of the goat virus, is protective for cattle against infection with a virulent LSD virus at immunizing doses from 15,000 to 80,000 TCID50, which are dependent on the LSD epizootic situation in particular region.

The Development of a Real-Time PCR Assay for Specific Detection of the NISKHI Sheep Pox Vaccine Virus Strain DNA

Sheep pox (SPP) constitutes a global animal health scourge, despite the numerous efforts targeting the eradication of the disease implemented in affected countries. An efficient control and eradication strategy incorporates the use of live attenuated vaccines, which in turn requires a method for differentiation between vaccinated and infected sheep. The NISKHI live attenuated SPP vaccine (LAV) is abundantly used in Russia, Kazakhstan and other Central Asian countries. This study describes the development and evaluation of a real-time PCR with a high-resolution melting assay, capable of differentiating the NISKHI vaccine virus from circulating virulent field strains. The RNA polymerase subunit RPO132 gene contains a unique single nucleotide polymorphism (SNP) capable of altering the melting curves of amplicons from LAV and virulent field isolates circulating in the region. The melting temperature (Tm) of field isolates ranged from 75.47 °C ± 0.04 to 75.86 °C ± 0.08, while the vaccine strain averaged 76.46 °C ± 0.12. Subsequent evaluation of this assay demonstrated that the recent SPP outbreaks in central Russia may be attributed to virulent field isolates. This robust assay was proven to consistently and differentially detect the NISKHI LAV strain when analyzing clinical samples from affected sheep.

Evaluation of antibody responses against the whole virions of goatpox and sheeppox viruses after subcutaneous immunization of rabbits

Antibody development is the integral process of generating and characterizing an antibody. It commences by inoculating the antigen of interest into laboratory animals, allowing the immune system develops large quantities of antibodies. This was aimed at developing antibodies against the virion of Goatpox and Sheeppox virus vaccines. The ability of Goatpox and Sheeppox vaccines was assessed. Regarding this study, the antibody titers against both Goatpox and Sheeppox viruses was increased in the same manner. The amount of IgG was determined to be 2.29 μg/μl and 2.18 μg/μl against virions of Goatpox virus and Sheeppox respectively. The purified IgG was analyzed by SDS-PAGE. Different bands of the purified antibodies were clearly visualized, and the molecular weight of IgG was estimated to be 67 kDa and 25 kDa. Additionally, antigen/antibody binding was confirmed by Western blot using GTPV A27 antigen. No significant differences in antibody titers were observed between the two groups (p < 0, 05).

Sero-Prevalence and Risk Factors for Sheep Pox and Its Comparison to Capri pox Double Antigen Multispecies Elisa in Kordofan States in Sudan

A cross-sectional survey was performed in the Kordofan region, from March to September 2011 was compared to Capripox Double Ag ELISA for multispecies. The estimated overall sero-prevalence of sheep pox in Kordofan region was 73.4% determined by virus neutralization and was prevalent in both South and North Kordofan states at 85% and 63.6% respectively. However, Seroprevalence for lumpy skin disease was 5% and 62% for sheep pox by using Capripox Double Ag ELISA. The serological information was used to identify potential risk factors associated with sheep pox outbreaks. The risk factors identified were the breed, age, sex, species, movement patterns, herd size and geographic region. In addition, a questionnaire explored producer’s knowledge about the disease in the Sudan. The results of the questionnaire were that both nomadic as well as fixed farmers were generally aware of sheep pox as a disease, but most did not have full knowledge about the disease. Greater than half of producers experienced the disease in the past 2 years and did not have their sheep vaccinated.

Genetic characterization of sheep pox virus strains from outbreaks in Central Russia in 2018-2019.

This study investigates the phylogenomic relatedness between sheep pox viruses (SPPVs) circulating in Central Russia in 2018-2019 with the NISKHI vaccine strain used in the country, based on their complete genome sequences. The sheep pox outbreaks occurred 1 year apart in the adjacent regions of Tula and Moscow. Full genome sequences were generated by sequencing DNA directly obtained from Trizol-extracted scabs, using the DNBSEQ-400 platform (MGI Tech, China). Phylogenetic analysis indicated that the SPPV isolates from Russia clusters with previously published sequences from Srinagar in the Kashmir province of India in 2000 (SPPV-Srinagar strain) as well as SPPV A strain from Kazakhstan in 2000. The aforementioned cluster belonged to a sister clade containing the NISKHI vaccine strain, thus indicating that the recent outbreaks were not genetically linked to the widely used vaccine.